COVID-19 Impact on PerkinElmer Inc.’s Revenue and Operations (Medical Devices)

COVID-19 Impact on PerkinElmer Inc.’s Revenue and Operations (Medical Devices)

  • December 2020 •
  • 11 pages •
  • Report ID: 5930814 •
  • Format: PDF
COVID-19 Impact on PerkinElmer Inc.’s Revenue and Operations (Medical Devices)

Summary
PerkinElmer Inc. (PerkinElmer), is a leading manufacture of products, services and solutions for In Vitro Diagnostics, headquartered in the United States with global manufacturing and sales reach. PerkinElmer’s product range includes the newly launched COVID-19 RT-PCR Test in its In Vitro Diagnostics segment, which is approved by FDA and now available in 30 countries worldwide. The report, COVID-19 Impact on PerkinElmer Inc.’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how PerkinElmer Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how PerkinElmer Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights
- While PerkinElmer was impacted early on in APAC due to the COVID-19 crisis, the company’s global performance has been positive in all regions.
- The geographic diversification of PerkinElmer’s business has been beneficial for generating revenue. With improved conditions in APAC, PerkinElmer has recuperated revenue from resumed sales in this region.

Scope
The report provides a comprehensive analysis of the impact of COVID-19 on PerkinElmer Inc. -
- It provides insights on PerkinElmer Inc.’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy
- An overview of how PerkinElmer Inc. will be affected by the COVID-19 pandemic.
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.